German politicians are considering making COVID-19 mandatory for their citizens, in light of the high incidence of infections and low vaccination rates.
Germany’s fourth wave of COVID rages and is currently discussing compulsory vaccination
Open Orphan PLC (ORPH.L) Imutex Vaccine Phase I Study Results
mutex to present positive Phase I clinical study results for AGS-v PLUS mosquito vaccine candidate AGS-v PLUS mosquito vaccine candidate shows favourable safety, tolerability, and immunogenicity results
Abingdon Health PLC (ABDX.L) Preliminary Results
York, U.K. 18 November 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces its preliminary results for the year
Poolbeg Pharma PLC (POLB.L) Update on POLB 001 Clinical Development
Rapidly progressing towards LPS challenge study
Open Orphan PLC (ORPH.L) £5.1m RSV Human Challenge Study Contract Win
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
Open Orphan PLC (ORPH.L) £1.5m Contract renewal for Venn Life Sciences
£1.5m Contract renewal for Venn Life Sciences with a major global pharmaceutical client
Genedrive PLC (GDR.L) Audited Final Results
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces its audited Final Results for the year ended 30 June 2021.
Omega Diagnostics Gp (ODX.L) Notice of Results and Investor Presentation
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, announces it will release its interim results for the
Omega Diagnostics Gp (ODX.L) Update on CTDA Regulations
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, notes the UK Health Security Agency’s Medical Devices (Coronavirus
Avacta Group PLC (AVCT.L) Update on UK Availability of AffiDX Test
Update on UK Availability of AffiDX SARS-CoV-2 Lateral Flow Rapid Antigen Test following Implementation of CTDA Regulations
Omega Diagnostics Gp (ODX.L) Partnership with DAM Health and initial LFT order
Agreement for Omega’s Market Leading, UK Manufactured VISITECT ® COVID-19 Antigen LFT
